Here's the live share price of Torrent Pharmaceuticals along with daily highs, lows, percentage changes and volume trends, and, all financial information.
Over the last 5 years, the share price of Torrent Pharmaceuticals has gained 22.92% CAGR. Over the past year, the corresponding return has been 14.70%.
Torrent Pharmaceuticals’s current P/E of 60.83x helps give context to how the market is valuing the stock based on recent earnings and growth expectations. Check out if this stock is part of our Large cap stocks Screener.
| Name | 1W(%) | 1M(%) | 3M(%) | 6M(%) | 1Y(%) | 3Y(%) | 5Y(%) | 
|---|---|---|---|---|---|---|---|
| Torrent Pharmaceuticals | 0.55 | 0.98 | -3.84 | 10.50 | 12.37 | 29.69 | 22.92 | 
| Sun Pharmaceutical Industries | 0.24 | 4.12 | -0.11 | -6.84 | -7.87 | 18.80 | 29.61 | 
| Divi's Laboratories | 0.89 | 16.39 | 0.70 | 8.95 | 12.77 | 22.60 | 16.18 | 
| Cipla | -2.73 | 1.76 | -0.88 | 0.97 | -0.82 | 9.72 | 15.36 | 
| Mankind Pharma | 0.58 | 0.29 | -4.75 | 2.68 | -8.28 | 19.76 | 11.42 | 
| Dr. Reddy's Laboratories | -6.37 | -3.54 | -5.41 | 1.63 | -5.66 | 10.70 | 4.22 | 
| Zydus Lifesciences | -1.94 | -0.57 | 1.66 | 11.37 | -1.57 | 31.49 | 18.74 | 
| Lupin | 0.57 | -1.98 | 0.71 | -5.60 | -11.15 | 40.64 | 16.42 | 
| Alkem Laboratories | -0.43 | 1.14 | 9.75 | 8.86 | -4.52 | 20.51 | 15.96 | 
| Aurobindo Pharma | 1.46 | 1.28 | -3.50 | -9.17 | -21.13 | 26.93 | 7.34 | 
| Abbott India | -1.07 | -0.83 | -13.94 | -3.67 | 2.24 | 15.44 | 14.12 | 
| Glenmark Pharmaceuticals | 3.55 | -3.86 | -11.72 | 36.89 | 11.21 | 66.99 | 31.70 | 
| Laurus Labs | 4.84 | 11.23 | 10.95 | 56.36 | 97.19 | 28.74 | 24.89 | 
| Biocon | 4.97 | 8.80 | -3.61 | 18.31 | 19.25 | 11.87 | -1.35 | 
| GlaxoSmithKline Pharmaceuticals | -4.99 | -3.03 | -17.26 | -8.39 | -3.93 | 23.79 | 12.26 | 
| Anthem Biosciences | -0.35 | -7.04 | -5.45 | -1.78 | -1.78 | -0.60 | -0.36 | 
| Ipca Laboratories | 1.61 | -2.97 | -12.56 | -6.54 | -18.86 | 12.52 | 2.18 | 
| Gland Pharma | -1.40 | -3.44 | -7.41 | 36.14 | 15.84 | 2.33 | 0.99 | 
| Ajanta Pharma | 1.97 | 2.59 | -10.54 | -4.78 | -19.89 | 23.76 | 18.58 | 
| Cohance Lifesciences | -11.52 | -10.79 | -22.19 | -31.65 | -41.00 | 24.95 | 19.81 | 
Over the last one year, Torrent Pharmaceuticals has gained 12.37% compared to peers like Sun Pharmaceutical Industries (-7.87%), Divi's Laboratories (12.77%), Cipla (-0.82%). From a 5 year perspective, Torrent Pharmaceuticals has outperformed peers relative to Sun Pharmaceutical Industries (29.61%) and Divi's Laboratories (16.18%).
| Day | SMA | EMA | 
|---|---|---|
| 5 | 3,591.91 | 3,593.06 | 
| 10 | 3,569.36 | 3,583.93 | 
| 20 | 3,559.9 | 3,576.04 | 
| 50 | 3,585.89 | 3,562.58 | 
| 100 | 3,498.34 | 3,504.73 | 
| 200 | 3,342.14 | 3,391.6 | 
In the latest quarter, Torrent Pharmaceuticals remained same as its previous close in promoter holding, while DII stake increased to 9.27%, FII holding fell to 15.92%, and public shareholding moved down to 6.47% compared to the previous quarter — reflecting a shift in investor sentiment across categories.
| Fund Name | No. Of Shares | % of AUM | Amount Invested(in ₹ crore) | 
|---|---|---|---|
| 30,15,904 | 2.84 | 1,086.69 | |
| 9,46,972 | 1.04 | 341.21 | |
| 8,46,654 | 3.98 | 305.07 | |
| 7,42,000 | 1.06 | 267.36 | |
| 4,63,748 | 0.96 | 167.1 | |
| 4,07,164 | 0.89 | 146.71 | |
| 4,00,000 | 3.66 | 144.13 | |
| 3,36,766 | 0.45 | 121.34 | |
| 3,30,930 | 0.35 | 119.24 | |
| 3,28,626 | 1.35 | 118.41 | 
* Excluding Index & Arbitrage Funds
| Price |   (%) As on Invalid Date IST | 
| Open Interest |   (%) | 
| High | |
| Low | |
| Open | |
| Close | |
| Contract Traded | |
| Turnover (in lakhs) | 
| Date Time | Announcement | 
|---|---|
| Oct 27, 2025, 11:24 PM IST | Torrent Pharmac - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation | 
| Oct 27, 2025, 10:11 PM IST | Torrent Pharmac - Board Meeting Intimation for Intimation Of The Date Of Board Meeting Under Regulation 29 Of The SEBI (List | 
| Oct 07, 2025, 9:47 PM IST | Torrent Pharmac - Announcement under Regulation 30 (LODR)-Credit Rating | 
| Oct 07, 2025, 8:31 PM IST | Torrent Pharmac - Announcement under Regulation 30 (LODR)-Credit Rating | 
| Oct 04, 2025, 9:41 PM IST | Torrent Pharmac - Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 | 
Torrent Pharmaceuticals Ltd. is a Public Limited Listed company incorporated on 15/07/1972 and has its registered office in the State of Gujarat, India. Company's Corporate Identification Number(CIN) is L24230GJ1972PLC002126 and registration number is 002126. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company's Total Operating Revenue is Rs. 9682.44 Cr. and Equity Capital is Rs. 169.23 Cr. for the Year ended 31/03/2025.
The share price of any company is dynamic and keeps changing depending on the trade initiated. The shares have a fixed opening rate and closing rate. The share price for Torrent Pharmaceuticals is ₹3,598.20 as on Oct 30, 2025.
The Torrent Pharmaceuticals is operating in the Pharmaceuticals and health care Sector. It is classified as a Largecap stock on the BSE.
The market cap of Torrent Pharmaceuticals is ₹121,779.44 Cr as on Oct 30, 2025.
Today’s highest and lowest price of Torrent Pharmaceuticals are ₹3,612.00 and ₹3,554.85.
The 52-week high/low is the highest and lowest price at which Torrent Pharmaceuticals stock has traded in the past 52-week or nearly a year. The 52-week high of Torrent Pharmaceuticals is ₹3,790.00 and 52-week low of Torrent Pharmaceuticals is ₹2,891.45 as on Oct 30, 2025.
The Torrent Pharmaceuticals has shown returns of -0.05% over the past day, -0.07% for the past month, -3.59% over 3 months, 14.7% over 1 year, 29.69% across 3 years, and 22.92% over 5 years.
P/E ratio of and PB ratio of Torrent Pharmaceuticals are 60.83 and 16.23 on Oct 30, 2025. While the company gives a dividend yield of 0.89 per annum.